Δημοσίευση

A Time Course of Bevacizumab (Anti-VEGF) Effect on Rat Peritoneum: Relations Between Antiadhesive Action and Fibrin Regulation Enzymes.

ΤίτλοςA Time Course of Bevacizumab (Anti-VEGF) Effect on Rat Peritoneum: Relations Between Antiadhesive Action and Fibrin Regulation Enzymes.
Publication TypeJournal Article
Year of Publication2017
AuthorsMicha, A-E., Psarras K., Ouroumidis O., Siska E., Vlachaki E., Lymperopoulos A., Symeonidis N., Nikolaidou C., Venizelos I., Koliakos G., & Pavlidis T. E.
JournalSurg Innov
Volume24
Issue6
Pagination543-551
Date Published2017 Dec
ISSN1553-3514
Λέξεις κλειδιάAngiogenesis Inhibitors, Animals, Bevacizumab, Cecum, Fibrinolysis, Male, Matrix Metalloproteinase 9, Peritoneum, Plasminogen Activator Inhibitor 1, Rats, Rats, Wistar, Tissue Adhesions, Tissue Plasminogen Activator
Abstract

BACKGROUND: To investigate the early and late antiadhesive effect and any changes of fibrin matrix regulation enzymes on rat peritoneum, after local administration of bevacizumab.METHODS: Rats were subjected to cecal abrasion. Bevacizumab (5 mg/kg) against placebo was given intraperitoneally. On the 2nd, 14th, and 28th postoperative days adhesions were scored, and tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-9 (MMP-9), degree of fibrosis, and angiogenesis were measured in abrased cecum and in intact parietal peritoneum.RESULTS: Bevacizumab significantly reduced adhesions up to 15% on the 2nd, 52.5% on the 14th, and 55% on the 28th postoperative day, and significantly increased tPA concentrations in peritoneum. PAI-1 was decreased, and a significantly higher tPA/PAI-1 ratio along with an increase of MMP-9 was measured at all time points. Fibrosis and angiogenesis were significantly lower on the 14th and 28th postoperative days.CONCLUSIONS: Local bevacizumab administration has a strong early and late antiadhesive action on rat peritoneum, mediated by changes in the tPA/PAI-1 and MMP balance in favor of fibrinolysis up to 28 days after operations.

DOI10.1177/1553350617729510
Alternate JournalSurg Innov
PubMed ID28877644

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.